Comparing Comorbid Profile and the Pattern of Non-Psychiatric Medicine Use Between Elderly and Non-Elderly Patients with Schizophrenia

سال انتشار: 1399
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 117

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IRJU-18-2_011

تاریخ نمایه سازی: 5 دی 1402

چکیده مقاله:

Objectives: Patients with schizophrenia receive psychiatric medications for many years, and their comorbid profile in old age remains unclear. Moreover, their pattern of non-psychiatric medicine use is of importance. Rehabilitation is crucial in patients with schizophrenia because it improves their strengths and life skills to live independently. These issues are essential in terms of polypharmacy among them, and its associated adverse effects.  Methods: The present cross-sectional study investigated ۱۳۱ patients with schizophrenia referring to Razi Hospital who were selected by a convenience sampling method. The subjects’ medical records were evaluated in terms of comorbid disorders and non-psychiatric medicine use patterns. Their demographic data were also collected by a separate questionnaire. Results: The frequency of schizophrenia disorder was higher in males aged ≥۶۵ years. The comorbidity frequency of non-psychiatric disorders was significantly higher in the elderly, compared to non-elderly patients. The most prevalent comorbid disorders in the elderly were musculoskeletal, cardiovascular, and metabolic disorders; and in the non-elderly neurological, hematological, and digestive diseases. The prevalence of non-psychiatric medicine intake was significantly higher in the elderly. The prevalence of non-psychiatric medicine use in the elderly (e.g. aspirin, heart disease medications, hypertension medications, etc.) and non-elderly patients (e.g. anemia medications, antibiotics, anticonvulsants, etc.) was not similar.  Discussion: In schizophrenic patients, the old age period is associated with more comorbid disorders, compared to their healthy counterparts. Such comorbid profile is similar to other patients; e.g. the most prevalent comorbidities were musculoskeletal, cardiovascular, and metabolic disorders. Polypharmacy is a medical problem in the elderly, with numerous adverse effects. The adjunct consumption of psychiatric medications with the non-psychiatric ones highlights the vital phenomena of drug interactions and associated adverse effects of polypharmacy.

نویسندگان

Arash Mirabzadeh

Social Determinants of Health Research Center, University of Social Welfare and rehabilitation Sciences, Tehran, Iran.

Gita Sadighi

Department of Psychiatry, School of Rehabilitation Sciences, University of Social Welfare and rehabilitation Sciences, Tehran, Iran.

Ahmadali Akbari Kamrani

Department of Clinical Science, Aging Research Center, School of Rehabilitation Sciences, University of Social Welfare and rehabilitation Sciences, Tehran, Iran.

Mohammadreza Khodaei Ardakani

Social Determinants of Health Research Center, University of Social Welfare and rehabilitation Sciences, Tehran, Iran.

Golnaz Feyzzadeh

Department of Psychiatry, School of Rehabilitation Sciences, University of Social Welfare and rehabilitation Sciences, Tehran, Iran.

Mercedeh Samiei

Department of Psychiatry, School of Rehabilitation Sciences, University of Social Welfare and rehabilitation Sciences, Tehran, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Correll CU, Rubio JM, Kane JM. What is the risk‐benefit ...
  • Fatima A, Barkat U, Mahmood KT, Zaka M. Schizophrenia in ...
  • Barnett A, Mackin P, Chaudhry I, Farooqi A, Gadsby R, ...
  • Hendrie HC, Lindgren D, Hay DP, Lane KA, Gao S, ...
  • Barbosa IG, Huguet RB, Mendonça VA, Sousa LP, Neves FS, ...
  • Jeste DV, Gladsjo JA, Lindamer LA, Lacro JP. Medical comorbidity ...
  • Nawka A, Kalisova L, Raboch J, Giacco D, Cihal L, ...
  • Cohen CI, Meesters PD, Zhao J. New perspectives on schizophrenia ...
  • Jeste DV, Maglione JE. Treating older adults with schizophrenia: challenges ...
  • Falkai P, Möller H-J. The functional sequelae of schizophrenia: consequences ...
  • Gurwitz JH. Polypharmacy: a new paradigm for quality drug therapy ...
  • Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, ...
  • Mangoni AA, Jackson SH. Age‐related changes in pharmacokinetics and pharmacodynamics: ...
  • Mannucci PM, Nobili A, Pasina L, Collaborators R. Polypharmacy in ...
  • Pare C. Unwanted effects of long-term medication in schizophrenia and ...
  • نمایش کامل مراجع